SCHEMBL4906333

SCHEMBL4906333

CCN(c1ccc(OCc2ccccc2)c(OC)c1)S(=O)(=O)c1cc(C(=O)O)c(C)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CTSV O60911 3/20 0.47
CTSL P07711 3/20 0.47
KEAP1 Q14145 3/20 0.46
NFE2L2 Q16236 3/20 0.46
APP P05067 2/20 0.46
ALDH1A1 P00352 1/20 0.46
NSD2 O96028 1/20 0.45
ESR1 P03372 1/20 0.45
POLB P06746 1/20 0.45
APEX1 P27695 1/20 0.45
RECQL P46063 1/20 0.45
ESR2 Q92731 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906067 0.87 KEAP1 (0.53) NPC1HPGDRAB9ASMN1; SMN2CTSV
SCHEMBL4902509 0.81 NSD2 (0.52) SMN1; SMN2NSD2ESR1POLBAPEX1
SCHEMBL4904503 0.80 KEAP1 (0.52) SMN1; SMN2KEAP1NFE2L2ALDH1A1TDP1
SCHEMBL7825765 0.77 CTSV (0.58) NPC1HPGDRAB9ASMN1; SMN2CTSV
SCHEMBL4906326 0.76 MTNR1A (0.54) SMN1; SMN2CTSVCTSLAPPALDH1A1
SCHEMBL8442834 0.73 RXRA (0.50) SMN1; SMN2CTSVCTSLALDH1A1POLB
SCHEMBL3112448 0.71 RXRA (0.59) SMN1; SMN2CTSVCTSLALDH1A1POLB
SCHEMBL4905993 0.71 LMNA (0.56) HPGDSMN1; SMN2KEAP1NFE2L2ALDH1A1
SCHEMBL242563 0.69 MRGPRX4 (0.77) NPC1HPGDRAB9ASMN1; SMN2CTSV
SCHEMBL11174592 0.69 TSHR (0.51) RAB9ASMN1; SMN2ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
EP-1765796-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS Pfizer Products Inc. (US) 2007-03-28 EP disclosed
WO-2006003495-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER PRODUCTS INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885HPGD 724/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.